Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision label in the site footer was updated to v3.3.4, with no changes to study data or page functionality.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a dedicated Locations section listing study sites (Alabama, Arkansas, Florida, Illinois, Maine, Maryland, South Carolina). Removed the older standalone location headers and the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check60 days agoChange DetectedThe PubMed-based publication attribution text was updated to indicate publications are auto-filled from PubMed and may not pertain to the study. The revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page no longer displays the government funding status notice about NIH operations and potential data processing delays. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedStudy Details page shows minor UI and textual updates with no changes to primary outcomes, inclusion/exclusion criteria, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check110 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.